5-(Phenylmethyl)-5-azaspiro[2.4]heptane-4,7-dione, 95%, 100mg

(2-(Difluoromethyl)pyridin-4-yl)methanol, 97%, 100mg

N-Methyl-1H-pyrazol-3-amine, 95.0%, 500mg

4-Nitro-L-phenylalanine methyl ester hydrochloride, 97.0%, 1g

5'-O-(4,4'-Dimethoxytrityl)thymidine>98.0%(HPLC)(T)5g

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

N-Phenethylbenzamide, 95.0%, 10g

6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide, 95.0%, 100g

2-Fluoro-5-(hydroxymethyl)benzonitrile, 95.0%, 25g

1-Benzyl-4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine, 97%, 25mg

4-Acetamidophenyl acetate, 98.0%, 10g

4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide hydrochloride, 95.0%, 1g

6-Chloro-9-methyl-9H-purine, 95.0%, 5g